These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
392 related articles for article (PubMed ID: 22155606)
1. Neurofibromatosis type 1-associated tumours: their somatic mutational spectrum and pathogenesis. Laycock-van Spyk S; Thomas N; Cooper DN; Upadhyaya M Hum Genomics; 2011 Oct; 5(6):623-90. PubMed ID: 22155606 [TBL] [Abstract][Full Text] [Related]
2. Exploring the somatic NF1 mutational spectrum associated with NF1 cutaneous neurofibromas. Thomas L; Spurlock G; Eudall C; Thomas NS; Mort M; Hamby SE; Chuzhanova N; Brems H; Legius E; Cooper DN; Upadhyaya M Eur J Hum Genet; 2012 Apr; 20(4):411-9. PubMed ID: 22108604 [TBL] [Abstract][Full Text] [Related]
3. Characterization of the somatic mutational spectrum of the neurofibromatosis type 1 (NF1) gene in neurofibromatosis patients with benign and malignant tumors. Upadhyaya M; Han S; Consoli C; Majounie E; Horan M; Thomas NS; Potts C; Griffiths S; Ruggieri M; von Deimling A; Cooper DN Hum Mutat; 2004 Feb; 23(2):134-146. PubMed ID: 14722917 [TBL] [Abstract][Full Text] [Related]
4. The NF1 somatic mutational landscape in sporadic human cancers. Philpott C; Tovell H; Frayling IM; Cooper DN; Upadhyaya M Hum Genomics; 2017 Jun; 11(1):13. PubMed ID: 28637487 [TBL] [Abstract][Full Text] [Related]
5. Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NF1 gene. Colman SD; Williams CA; Wallace MR Nat Genet; 1995 Sep; 11(1):90-2. PubMed ID: 7550323 [TBL] [Abstract][Full Text] [Related]
6. Cutaneous neurofibromas in the genomics era: current understanding and open questions. Allaway RJ; Gosline SJC; La Rosa S; Knight P; Bakker A; Guinney J; Le LQ Br J Cancer; 2018 Jun; 118(12):1539-1548. PubMed ID: 29695767 [TBL] [Abstract][Full Text] [Related]
7. Toward a survey of somatic mutation of the NF1 gene in benign neurofibromas of patients with neurofibromatosis type 1. Eisenbarth I; Beyer K; Krone W; Assum G Am J Hum Genet; 2000 Feb; 66(2):393-401. PubMed ID: 10677298 [TBL] [Abstract][Full Text] [Related]
8. Comprehensive NF1 screening on cultured Schwann cells from neurofibromas. Maertens O; Brems H; Vandesompele J; De Raedt T; Heyns I; Rosenbaum T; De Schepper S; De Paepe A; Mortier G; Janssens S; Speleman F; Legius E; Messiaen L Hum Mutat; 2006 Oct; 27(10):1030-40. PubMed ID: 16941471 [TBL] [Abstract][Full Text] [Related]
9. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications. Gottfried ON; Viskochil DH; Couldwell WT Neurosurg Focus; 2010 Jan; 28(1):E8. PubMed ID: 20043723 [TBL] [Abstract][Full Text] [Related]
10. Somatic NF1 mutational spectrum in benign neurofibromas: mRNA splice defects are common among point mutations. Serra E; Ars E; Ravella A; Sánchez A; Puig S; Rosenbaum T; Estivill X; Lázaro C Hum Genet; 2001 May; 108(5):416-29. PubMed ID: 11409870 [TBL] [Abstract][Full Text] [Related]
11. Advances in the treatment of neurofibromatosis-associated tumours. Lin AL; Gutmann DH Nat Rev Clin Oncol; 2013 Nov; 10(11):616-24. PubMed ID: 23939548 [TBL] [Abstract][Full Text] [Related]
12. Somatic alterations of the NF1 gene in an NF1 individual with multiple benign tumours (internal and external) and malignant tumour types. Spurlock G; Griffiths S; Uff J; Upadhyaya M Fam Cancer; 2007; 6(4):463-71. PubMed ID: 17551851 [TBL] [Abstract][Full Text] [Related]
13. Gastric carcinoid: germline and somatic mutation of the neurofibromatosis type 1 gene. Stewart W; Traynor JP; Cooke A; Griffiths S; Onen NF; Balsitis M; Shah AA; Upadhyaya M; Tobias ES Fam Cancer; 2007; 6(1):147-52. PubMed ID: 16944271 [TBL] [Abstract][Full Text] [Related]
14. A search for evidence of somatic mutations in the NF1 gene. John AM; Ruggieri M; Ferner R; Upadhyaya M J Med Genet; 2000 Jan; 37(1):44-9. PubMed ID: 10633134 [TBL] [Abstract][Full Text] [Related]
15. Germline and somatic NF1 mutations in sporadic and NF1-associated malignant peripheral nerve sheath tumours. Bottillo I; Ahlquist T; Brekke H; Danielsen SA; van den Berg E; Mertens F; Lothe RA; Dallapiccola B J Pathol; 2009 Apr; 217(5):693-701. PubMed ID: 19142971 [TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics and NF1 gene mutation analysis of three successive generations in three different Indian families with neurofibromatosis type 1 and peripheral nerve sheath tumours. Prasad BCM; Chandra VVR; Sudarsan A; Kumar PS; Sarma PVGK J Clin Neurosci; 2018 Jul; 53():62-68. PubMed ID: 29680440 [TBL] [Abstract][Full Text] [Related]
17. Genetic basis of neurofibromatosis type 1 and related conditions, including mosaicism. Legius E; Brems H Childs Nerv Syst; 2020 Oct; 36(10):2285-2295. PubMed ID: 32601904 [TBL] [Abstract][Full Text] [Related]
18. Confirmation of a double-hit model for the NF1 gene in benign neurofibromas. Serra E; Puig S; Otero D; Gaona A; Kruyer H; Ars E; Estivill X; Lázaro C Am J Hum Genet; 1997 Sep; 61(3):512-9. PubMed ID: 9326316 [TBL] [Abstract][Full Text] [Related]
19. The heterogeneous nature of germline mutations in NF1 patients with malignant peripheral serve sheath tumours (MPNSTs). Upadhyaya M; Spurlock G; Majounie E; Griffiths S; Forrester N; Baser M; Huson SM; Gareth Evans D; Ferner R Hum Mutat; 2006 Jul; 27(7):716. PubMed ID: 16786508 [TBL] [Abstract][Full Text] [Related]
20. Germline Neurofibromin 1 mutation enhances the anti-tumour immune response and decreases juvenile myelomonocytic leukaemia tumourigenicity. Wang W; Li X; Qin X; Miao Y; Zhang Y; Li S; Yao R; Yang Y; Yu L; Zhu H; Song L; Mao S; Wang X; Chen J; Feng H; Li Y Br J Haematol; 2023 Jul; 202(2):328-343. PubMed ID: 37144690 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]